---
title: "AI application stocks continue to strengthen, Arcvideo Tech hits the 20% limit up in the afternoon"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/251763857.md"
description: "AI application stocks continued to strengthen in the afternoon, with Arcvideo Tech hitting a 20% limit up in the afternoon. BONCloud and DHKJ previously hit the limit up, while CTFO, Wondertek, CloudWalk Technology, Fengyuzhu, and Lingyun Optics saw gains of over 5%"
datetime: "2025-08-06T06:03:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251763857.md)
  - [en](https://longbridge.com/en/news/251763857.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251763857.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/251763857.md) | [繁體中文](https://longbridge.com/zh-HK/news/251763857.md)


# AI application stocks continue to strengthen, Arcvideo Tech hits the 20% limit up in the afternoon

AI application stocks continued to strengthen in the afternoon, with Arcvideo Tech hitting the 20% limit up, BONCloud and DHKJ previously hitting the limit up, and CTFO, Wondertek, CloudWalk Technology, Fengyuzhu, and Lingyun Optics among several stocks rising over 5%

### 相关股票

- [Arcvideo Tech (688039.CN)](https://longbridge.com/zh-CN/quote/688039.CN.md)
- [BONCloud (300166.CN)](https://longbridge.com/zh-CN/quote/300166.CN.md)
- [DHKJ (600288.CN)](https://longbridge.com/zh-CN/quote/600288.CN.md)
- [CTFO (002373.CN)](https://longbridge.com/zh-CN/quote/002373.CN.md)
- [Wondertek (603189.CN)](https://longbridge.com/zh-CN/quote/603189.CN.md)
- [Fengyuzhu (603466.CN)](https://longbridge.com/zh-CN/quote/603466.CN.md)

## 相关资讯与研究

- [China AI giants offer better value than US peers, top fund says](https://longbridge.com/zh-CN/news/278962257.md)
- [Hengrui Pharma Secures Nod to Market Likang Kepan Fumarate Drug](https://longbridge.com/zh-CN/news/279355808.md)
- [14:00 ETLowrider Stamps Cruising Into a Post Office Near You](https://longbridge.com/zh-CN/news/279078476.md)
- [Hengrui Pharma's Subsidiary Gets Nod for Clinical Trial of Atopic Dermatitis Drug Combination](https://longbridge.com/zh-CN/news/279354247.md)
- [Jiangsu Hengrui Pharmaceutical Gets China Nod for Blood Autoimmune Disease Drug](https://longbridge.com/zh-CN/news/279231502.md)